Singapore’s Medical Tourism Industry: Growth, Opportunities, and Future Trends
Singapore has established itself as one of the leading destinations for medical tourism, attracting patients from across the world seeking high-quality healthcare. In 2024, Singapore welcomed approximately 646,000 international patients, generating an estimated US$ 270 million in revenue.
With its internationally accredited hospitals, advanced medical technologies, and highly trained specialists, the city-state remains a top choice for those prioritizing world-class treatment.
Beyond being a premier healthcare provider, medical tourism plays a vital role in Singapore’s economy, contributing to job creation and reinforcing its reputation as a global medical hub. As competition from regional players intensifies, Singapore continues to leverage its technological advancements and regulatory support to maintain its edge in the industry.
Evolution of medical tourism in Singapore
Early developments and strategic Initiatives
Singapore’s rise as a medical tourism destination is rooted in its strategic efforts to develop a world-class healthcare ecosystem. Key milestones include:
- 2003: Launch of the “SingaporeMedicine” initiative, a government-backed program designed to position Singapore as a medical hub.
- 2006: Expansion of specialized healthcare facilities, including the National Heart Centre and National Cancer Centre.
- 2010: Inauguration of Khoo Teck Puat Hospital, further enhancing Singapore’s medical infrastructure.
- 2020: Opening of Outram Community Hospital, increasing capacity for specialized treatments and post-surgical care.
- 2024: A record 646,000 international patients received medical treatment in Singapore, reinforcing its position as a trusted healthcare destination.
Government policies driving growth
Singapore’s government has played a crucial role in fostering medical tourism through key policies:
- SingaporeMedicine Initiative – A multi-agency effort involving the Ministry of Health (MOH), Singapore Tourism Board (STB), and Economic Development Board (EDB) to attract international patients.
- Healthcare 2020 Masterplan – A long-term strategy to improve medical services, increase hospital capacity, and ensure affordability.
- Medical Tourism Visa – Special visa arrangements for international patients, easing travel and treatment processes.
Singapore’s competitive edge in healthcare
Internationally accredited healthcare facilities
Singapore is home to 23 Joint Commission International (JCI)-accredited hospitals and healthcare institutions, underscoring its commitment to meeting global standards. Singapore General Hospital has consistently ranked among the world’s best hospitals, further strengthening the country’s credibility in medical excellence.
Highly skilled medical workforce
Singapore maintains a strong healthcare workforce, with approximately 2.6 doctors per 1,000 people. Many of these professionals have received training from top global institutions, ensuring that patients receive the highest standard of care. Additionally, 93.1 percent of non-resident doctors in Singapore were trained overseas, bringing in specialized expertise from different parts of the world.
Advanced medical technology and innovation
Singapore is at the forefront of healthcare innovation, leveraging cutting-edge technology to improve patient outcomes.
- Robot-assisted surgeries – Widely adopted in leading hospitals, with technologies like the da Vinci Surgical System enhancing precision in complex procedures.
- AI in diagnostics – Singapore has a 53 percent AI deployment rate in healthcare, surpassing the global average, helping to improve early disease detection and treatment effectiveness.
- Electronic Medical Records (EMRs) – Over 90 percent of public healthcare institutions have adopted the National Electronic Health Record (NEHR) system, streamlining patient data access across hospitals and clinics.
Specialties that attract international patients
Singapore excels in a wide range of medical specialties that attract patients from around the world:
- Oncology treatments – Advanced cancer treatments, including targeted therapies and proton beam therapy.
- Cardiac and cardiovascular procedures – Renowned heart treatment centers specializing in minimally invasive surgeries.
- Orthopedic surgeries – Leading-edge procedures for joint replacements and spinal surgery.
- Fertility treatments – Cutting-edge IVF programs with high success rates.
- Cosmetic and reconstructive surgeries – High standards of safety and aesthetics in plastic surgery.
- Complex transplant procedures – Liver, kidney, and bone marrow transplants performed with world-class expertise.
Economic impact of medical tourism
Revenue and contribution to GDP
Singapore’s medical tourism sector has demonstrated steady growth, with revenue increasing from US$ 220 million in 2020 to US$ 270 million in 2024. Despite its relatively small share of 0.1 percent of GDP, medical tourism is a vital contributor to the nation’s healthcare revenue and overall economy.
Employment and industry growth
The sector directly and indirectly supports around 15,000 jobs, spanning healthcare, hospitality, and medical tourism facilitation services. The growing demand for premium healthcare services has fueled investment in new hospital expansions and research initiatives, further stimulating job creation and economic growth.
Challenges facing Singapore’s medical tourism industry
Despite its strengths, Singapore faces several challenges that could impact the future growth of medical tourism, including high treatment costs that make it less accessible compared to regional competitors, increasing competition from destinations like Thailand and Malaysia, visa and travel restrictions that can deter international patients, and stringent healthcare regulations that sometimes slow down the adoption of new treatments and innovations.
The future of medical tourism in Singapore
Singapore’s future in medical tourism will be shaped by innovations in digital health, precision medicine, and strategic investments in cutting-edge healthcare solutions. A key factor driving this transformation is the increasing adoption of telemedicine, with 65 percent of international patients utilizing teleconsultations before traveling for treatment. By streamlining the patient journey, this shift enhances accessibility and efficiency while also enabling more personalized care through preliminary diagnoses and treatment planning before arrival.
These technological advancements are fueling significant growth in Singapore’s medical tourism industry, which is projected to expand at a CAGR of 19.7 percent from 2023 to 2033, positioning the country as a leader in medical innovation. The government also remains committed to research and development, implementing supportive policies to sustain innovation in healthcare. Strategic investments from global pharmaceutical giants—such as AstraZeneca’s US$ 1.5 billion cancer treatment project—demonstrate confidence in the country’s healthcare ecosystem. Moreover, the growing integration of artificial intelligence, robotic-assisted procedures, and telemedicine is expected to optimize patient outcomes and streamline medical processes, enhancing Singapore’s appeal to international patients seeking cutting-edge treatment solutions.
About Us
ASEAN Briefing is one of five regional publications under the Asia Briefing brand. It is supported by Dezan Shira & Associates, a pan-Asia, multi-disciplinary professional services firm that assists foreign investors throughout Asia, including through offices in Jakarta, Indonesia; Singapore; Hanoi, Ho Chi Minh City, and Da Nang in Vietnam; besides our practices in China, Hong Kong SAR, India, Italy, Germany, and USA. We also have partner firms in Malaysia, Bangladesh, the Philippines, Thailand, and Australia.
Please contact us at asean@dezshira.com or visit our website at www.dezshira.com and for a complimentary subscription to ASEAN Briefing’s content products, please click here.